Free Trial

Semper Paratus Acquisition (LGSTW) Competitors

$0.05 +0.00 (+2.48%)
As of 05/30/2025

LGSTW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Semper Paratus Acquisition stock or one of its competitors? The main competitors of Semper Paratus Acquisition include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Semper Paratus Acquisition vs.

180 Life Sciences (NASDAQ:ATNFW) and Semper Paratus Acquisition (NASDAQ:LGSTW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

180 Life Sciences and Semper Paratus Acquisition both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Semper Paratus AcquisitionN/AN/A

In the previous week, 180 Life Sciences had 1 more articles in the media than Semper Paratus Acquisition. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Semper Paratus Acquisition. 180 Life Sciences' average media sentiment score of 1.89 beat Semper Paratus Acquisition's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Very Positive
Semper Paratus Acquisition Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Semper Paratus Acquisition N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Semper Paratus AcquisitionN/AN/AN/AN/AN/A

Summary

180 Life Sciences beats Semper Paratus Acquisition on 2 of the 2 factors compared between the two stocks.

Get Semper Paratus Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for LGSTW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LGSTW vs. The Competition

MetricSemper Paratus AcquisitionShell Companies IndustryFinancial SectorNASDAQ Exchange
Market CapN/A$381.24M$5.77B$8.42B
Dividend YieldN/A4.81%4.17%4.17%
P/E RatioN/A0.5412.9019.79
Price / SalesN/A383.131,738.67134.00
Price / CashN/A217.8149.8334.64
Price / BookN/A2.941.354.50
Net IncomeN/A-$141.08M$1.14B$248.30M
7 Day PerformanceN/A0.12%0.57%0.99%
1 Month PerformanceN/A0.12%9.15%7.48%
1 Year PerformanceN/A12.39%13.49%8.72%

Semper Paratus Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LGSTW
Semper Paratus Acquisition
N/A$0.05
+2.5%
N/A+34.5%$0.00N/A0.003Gap Up
ATNFW
180 Life Sciences
N/A$0.01
+1.4%
N/A+11.1%$0.00N/A0.007Positive News
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
+5.3%
N/A-89.2%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.21
+48.9%
N/A+255.9%$0.00$106,207.000.0040Gap Down
ALVOW
Alvotech
N/A$1.80
flat
N/A-31.5%$0.00$585.60M0.004Positive News
Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
+25.0%
N/A-74.6%$0.00N/A0.0015Gap Up
High Trading Volume
BFRIW
Biofrontera
N/A$0.09
-18.1%
N/A+53.3%$0.00$38.00M0.0070Positive News
Gap Down
BTMDW
biote
N/A$0.02
+0.5%
N/AN/A$0.00$199.38M0.00N/AGap Up
High Trading Volume
BCTXW
BriaCell Therapeutics
N/A$0.10
-4.6%
N/A-82.2%$0.00N/A0.008Positive News
Short Interest ↓
CELUW
Celularity
N/A$0.04
-33.3%
N/A+100.5%$0.00$54.22M0.00220Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:LGSTW) was last updated on 6/1/2025 by MarketBeat.com Staff
From Our Partners